Story perspectives

UK Unveils £29.6m RNA Biofoundry to Boost Health Innovation

8/30/2025

30 4

Summary

Story summary

The UK will establish the RNA Biofoundry in Darlington with £29.6m government funding to advance RNA therapies for diseases.
The facility will enhance RNA development, improve pandemic preparedness, and facilitate quicker NHS treatment access.
New Zealand has created over 500 vaccines through its mRNA Platform, focusing on local research amid US funding cuts.
The pre-pandemic Kiwi Vax vaccine demonstrates New Zealand's rapid response capability to health crises.

1 of 1

Story summary

The UK will establish the RNA Biofoundry in Darlington with £29.6m government funding to advance RNA therapies for diseases.
The facility will enhance RNA development, improve pandemic preparedness, and facilitate quicker NHS treatment access.
New Zealand has created over 500 vaccines through its mRNA Platform, focusing on local research amid US funding cuts.
The pre-pandemic Kiwi Vax vaccine demonstrates New Zealand's rapid response capability to health crises.